Know Cancer

or
forgot password

High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation


N/A
18 Years
N/A
Not Enrolling
Male
Prostatic Neoplasm

Thank you

Trial Information

High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation


Inclusion Criteria:



- Suitable candidate for prostate brachytherapy to treat prostate cancer

- Patient signs a study consent form

Exclusion Criteria:

- Have received other radiotherapy for prostate cancer or hormone treatments

- Has contraindication to MRSI scanning

- Does not sign study consent form

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

pilot study meant to establish scanning parameters on 3T MRSI

Principal Investigator

Don Yee, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Alberta Health Services

Authority:

Canada: Health Canada

Study ID:

NA-15-0003 / 22011

NCT ID:

NCT00126854

Start Date:

October 2005

Completion Date:

April 2011

Related Keywords:

  • Prostatic Neoplasm
  • brachytherapy
  • magnetic resonance spectroscopy
  • Neoplasms
  • Prostatic Neoplasms

Name

Location